Twin Pregnancy Following Sirolimus Therapy in Lymphangioleiomyomatosis

Twin Pregnancy in Lymphangiomyeiomatosis
Vol. 17 No. 1 : 2022 (282-287)

ANDREA YLB
ANDREA YLB
Mas Fazlin MJ
Mas Fazlin MJ
Ng BH
Ng BH
Nik Nuratiqah NA
Nik Nuratiqah NA
MOHAMED FAISAL AH
MOHAMED FAISAL AH

Abstract
Lymphangioleiomyomatosis (LAM) is an orphan cystic lung disease which can occur sporadically or in association with tuberous sclerosis complex (TSC). We report a 26-year-old woman diagnosed with forme fruste of LAM, who presented with bilateral  pneumothoraces requiring both surgical and medical pleurodesis. Clinical examination and investigations revealed hepatic and renal angiomyolipomas, a left retinal hamartoma, subcortical tubers and subependymal nodules in the brain  as well as diffuse bilateral thin-walled lung cysts of varying sizes bilaterally. The histopathological examination (HPE) of the lung biopsy confirmed LAM. She was treated with 12 months of sirolimus with sustained effects on lung function and cystic lung lesions. Eight months post cessation of sirolimus, she conceived and delivered twins at 30 weeks. We describe the efficacy and safety of sirolimus and the successful twin pregnancy in a patient with LAM. This case highlights that treatment  with sirolimus and surgical and medical pleurodesis was successful in preventing any further worsening of lung function. 

Keywords : Lymphangioleiomyomatosis, pregnancy, sirolimus, twin,

Correspondance Address
Mohamed Faisal Abdul Hamid. Respiratory Unit, Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603-9145 6082 Email: faisal.hamid@ppukm.ukm.edu.my